CGN Advisors’s Aptus Defined Risk ETF DRSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,928
Closed -$229K 219
2022
Q4
$229K Sell
8,928
-2,771
-24% -$71.1K 0.04% 209
2022
Q3
$297K Sell
11,699
-13,493
-54% -$358K 0.07% 188
2022
Q2
$662K Sell
25,192
-250,516
-91% -$6.75M 0.19% 132
2022
Q1
$7.71M Buy
275,708
+40,501
+17% +$1.15M 1.92% 7
2021
Q4
$6.79M Buy
235,207
+23,284
+11% +$678K 1.77% 10
2021
Q3
$6.07M Buy
211,923
+16,742
+9% +$495K 1.98% 8
2021
Q2
$5.78M Buy
195,181
+4,359
+2% +$129K 1.83% 11
2021
Q1
$5.59M Buy
190,822
+24,689
+15% +$729K 2.01% 10
2020
Q4
$4.88M Buy
+166,133
New +$5M 1.95% 10

Other funds holding DRSK

CGN Advisors's DRSK Position: Q1 2023 in Review

CGN Advisors sold out of Aptus Defined Risk ETF (DRSK) in Q1 2023, closing a stake of 8,928 shares — an estimated $229K sold.

CGN Advisors first reported a position in DRSK in Q4 2020 and held it in 9 quarters. The position peaked at $7.71M in Q1 2022. 62 funds tracked by Wall St. Rank hold DRSK as of Q1 2023.

  • CGN Advisors reported no remaining Aptus Defined Risk ETF position as of Q1 2023 after selling out during the quarter.
  • CGN Advisors sold 8,928 Aptus Defined Risk ETF shares in Q1 2023, an estimated $229K.
  • CGN Advisors first reported a position in Aptus Defined Risk ETF in Q4 2020 and held it in 9 quarters.
  • CGN Advisors's Aptus Defined Risk ETF position peaked at $7.71M in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Aptus Defined Risk ETF as of Q1 2023.

Based on CGN Advisors's 13F filing for Q1 2023, filed 4 Apr 2023.